Canine CA199 antibody and antigen (recombinant protein)

 Download 

Product information

Catalog No.	Description	US $ Price (per mg)
GMP-CAN-CA199-Ag01	Recombinant Canine CA199 protein	3090
GMP-CAN-CA199-Ab01	Anti-Canine CA199 mouse monoclonal antibody (mAb)	1953
GMP-CAN-CA199-Ab02	Anti-Canine CA199 mouse monoclonal antibody (mAb)	1953
GMP-CAN-CA199-Ab03	Anti-Canine CA199 human monoclonal antibody (mAb)	1953
GMP-CAN-CA199-Ab04	Anti-Canine CA199 human monoclonal antibody (mAb)	1953

Size： 1mg | 10mg | 100mg

Product Description

Cat No. of Products	GMP-CAN-CA199-Ag01
Product Name	Recombinant Canine CA199 protein
Target/Biomarker	Canine Carbohydrate antigen 19-9 (IBV - Variant D1466)
Expression platform	E.coli
Isotypes	Recombinant Antigen
Bioactivity validation	Anti-Canine Carbohydrate antigen 19-9 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in IBV - Variant D1466 level test of animal Dog/Canine with pancreatic and biliary tract tumors.
Tag	His
Products description	Recombinant Canine CA199 protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-CAN-CA199-Ab01, GMP-CAN-CA199-Ab02
Product Name	Anti-Canine CA199 mouse monoclonal antibody (mAb)
Target/Biomarker	Canine Carbohydrate antigen 19-9 (IBV - Variant D1466)
Expression platform	CHO
Isotypes	Mouse IgG
Bioactivity validation	Recombinant Canine Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant D1466 antibodies in IBV - Variant D1466 level test of animal Dog/Canine with pancreatic and biliary tract tumors.
Tag	mFc
Products description	Anti-Canine CA199 mouse monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant D1466 antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products	GMP-CAN-CA199-Ab03, GMP-CAN-CA199-Ab04
Product Name	Anti-Canine CA199 human monoclonal antibody (mAb)
Target/Biomarker	Canine Carbohydrate antigen 19-9 (IBV - Variant D1466)
Expression platform	CHO
Isotypes	Human IgG1
Bioactivity validation	Recombinant Canine Carbohydrate antigen 19-9 antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant D1466 antibodies in IBV - Variant D1466 level test of animal Dog/Canine with pancreatic and biliary tract tumors.
Tag	hFc
Products description	Anti-Canine CA199 human monoclonal antibody (mAb) is a monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-IBV - Variant D1466 antibodies.
Purity	Purity: ≥95% (SDS-PAGE)
Application	Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays
Formulation & Reconstitution	Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage	Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference

Validation Data

Click to get more Data / Case study about the product.

Target/Biomarker information

Cancer Antigen 199 (CA199) is a glycoprotein biomarker with vital implications in the realm of canine health. This biomarker is primarily associated with the diagnosis and monitoring of cancer in dogs (canines), particularly cancers affecting the pancreas and gastrointestinal tract. CA199 stands out due to its unique structure, characterized by a protein core to which carbohydrate molecules are attached. In the context of canine health, CA199 is a key player in the identification of cancer. When cancer cells, especially those found in pancreatic and gastrointestinal cancers, proliferate within a dog's body, they produce and release CA199 into the bloodstream. This glycoprotein can be detected through blood tests, offering a non-invasive means of diagnosing and monitoring these types of cancer. CA199 is not exclusive to cancer diagnosis; it also has value in assessing the response to cancer treatment in dogs. Monitoring changes in CA199 levels over time can provide critical insights into the effectiveness of therapeutic interventions. This dynamic approach enables veterinarians to tailor treatment strategies to individual canine patients, optimizing their care and enhancing their overall well-being.

About GDU